inovations_data_centre.jpgSanger Institute, Genome Research Limited

We turn ideas into reality

We seek to deliver therapeutic, diagnostic and production benefits in areas as diverse as cancer, immunology, public health and personalised treatment



Creating a CRISPR Community

The Sanger Institute and Astra Zeneca recently co-organised an inaugural Sanger Institute-AstraZeneca conference centred on the application of CRISPR technology to the understanding and treatment of human disease.

The meeting took place on 18-19 January 2016 at the Wellcome Genome Campus Conference Centre, Cambridge UK.

The goal of Creating a CRISPR Community was to foster networking and collaborations between scientists from academia and the pharmaceutical and biotechnology industries who are applying CRISPR systems to the study of human disease and its treatment. Sessions explored advances in genome editing technology, DNA repair, disease model, CRISPR-based genome-wide screening, therapeutic applications of CRISPR and routes to the clinic.

Read a summary of the conference published by Genome Web: “ Sanger, AstraZeneca Host CRISPR Conference With Focus on Human Biology, Public-Private Bridge “